“…Several studies have been carried out in which different molecules have been identified to interact with eEF1A, either involving the entire protein or just localized regions within specific domains, some reviewed in section 1.3.3.1. Thus, it has been shown that (i) F-actin interacts with domains I and III of Dictyostelium EF1α (Liu, et al, 1996) and domain II of human eEF1A from an epidermoid cancer cell line (Lamberti, et al, 2008); (ii) activation-induced deaminase (AID) binds to Domain III of eEF1A leading to cytoplasmic retention (Hälser, Rada and Neuberger, 2012); (iii) SH3 domain-containing adaptor protein SORBS2, involved in the assembly of signaling complexes, interacts with domain II of eEF1A1 near the membrane (Lamberti, et al, 2011); and (iv) SH2 and SH3 domains of diverse signaling molecules, such as Crk, Fgr, Fyn, Grb2, RasGAP, Shc and Shp2, possess different abilities to bind to phosphotyrosine-containing sites in domain I of both eEF1A1 and eEF1A2 (Panasyuk, et al, 2008). Further studies directed at characterizing eEF1A complexes and the PTMs involved are required to clarify, at the molecular level, the plethora of events in which this elongation factor is involved.…”